COMMUNIQUÉS West-GlobeNewswire

LIDDS: Presenterar Årsredovisning 2017

25/04/2018 - 20:34

För mer information, vänligen kontakta: Monica Wallter, CEO, +46 (0)737 07 09 22, monica.wallter@liddspharma.com Bengt Norvik, CFO, +46 (0)730 74 68 00, bengt.norvik@liddspharma.com LIDDS utvecklar effektiva läkemedel [...]

Sharecare to be featured during three sessions at HLTH in Las Vegas

25/04/2018 - 20:20

Company's co-founder and CEO Jeff Arnold and Blue Zones founder Dan Buettner to speak during general session on Monday, May 7 ATLANTA, April 25, 2018 (GLOBE NEWSWIRE) -- Sharecare, the digital health company helping [...]

Portola Pharmaceuticals to Present New Interim Phase 2 Data for Cerdulatinib at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

25/04/2018 - 19:06

– Novel Oral SYK/JAK Inhibitor for Relapsed/Refractory B-cell and T-cell Cancers – SOUTH SAN FRANCISCO, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA ) today announced that new [...]

Decisions of the Annual General Meeting of Biohit Oyj

25/04/2018 - 19:00

Biohit Oyj Decisions of the Annual General Meeting April 25, 2018 at 8:00 pm local time (EEST) The Annual General Meeting (AGM) of Biohit Oyj held on Wednesday April 25, 2018 adopted the financial statements of the [...]

Aixplorer Mach 30 SuperSonic Imagine Pushes the Boundaries of Ultrasound Imaging

25/04/2018 - 19:00

With its sleek, functional design, new user experience and greater simplicity, the new SuperSonic Imagine’s ultrasound platform integrates the unique technological innovations such as the SonicPad and increased [...]

Stealth Mark Collaborates with Oak Ridge National Labs on Next Generation Authentication

25/04/2018 - 18:17

HOFFMAN ESTATES, IL , April 25, 2018 (GLOBE NEWSWIRE) -- Wellness Center USA, Inc.’s (OTCQB: WCUI ) wholly-owned subsidiary, StealthCo, Inc., dba Stealth Mark, is pleased to announce that they have concluded licensing [...]

Immunomedics Announces Oral Presentation of Sacituzumab Govitecan in Hormone Receptor-Positive (HR+) Metastatic Breast Cancer (mBC) at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

25/04/2018 - 18:15

Company to Host Investor Event on June 3, 2018 MORRIS PLAINS, N.J., April 25, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU ) (“Immunomedics” or the “Company”), a leader in the field of antibody-drug [...]

Genmab Announces Data to be Presented at 2018 ASCO Annual Meeting

25/04/2018 - 17:59

Media Release 11 industry sponsored abstracts regarding Genmab programs scheduled for presentation at ASCO Annual Meeting One oral presentation, three poster discussion sessions and seven poster presentations Copenhagen [...]

BioSyent to Present at Upcoming Investor Conferences

25/04/2018 - 17:45

TORONTO, April 25, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”) (TSX Venture:RX) is pleased to announce that it will be presenting at the following upcoming investor conferences: May 2, 2018 - Bloom Burton & [...]

CV Sciences, Inc. Fully Retires Convertible Debt

25/04/2018 - 17:08

Company Fully Repays Outstanding Convertible Debt and Avoids Dilution to Stockholders LAS VEGAS, April 25, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company,” “CV Sciences,” “our” or “we”) announced [...]

Tauriga Sciences Inc. to Present at European Institutional Investor Conference on June 21, 2018 in Berlin, Germany; Venue is the Representative Office of Baden-Wurttemberg in Berlin

25/04/2018 - 17:01

NEW YORK, NY, April 25, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG ) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of [...]

Tauriga Sciences Inc. Board of Directors Approves 1 for 75 Reverse Split, Reducing Its Outstanding Common Stock to Approximately 52,300,000 Shares With a Proportional Reduction of Its Authorized Common Stock to 100,000,000 Shares

25/04/2018 - 16:10

NEW YORK, NY, April 25, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG ) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of [...]

Scythian Biosciences Corp. Announces the Appointment of European Cannabis Leader Rob Reid of Prohibition Partners as CEO

25/04/2018 - 15:06

– In addition Scythian announces Liberty Health Sciences CEO George Scorsis as Chairman of the Board and Welcomes Back Rogers Communications Executive Roger Rai to the Board TORONTO, April 25, 2018 (GLOBE NEWSWIRE) -- [...]

Progyny and RESOLVE to Ring the Nasdaq Stock Market Closing Bell in Recognition of National Infertility Awareness Week®

25/04/2018 - 15:00

New York City, April 25, 2018 (GLOBE NEWSWIRE) -- Progyny, the leading fertility benefits management company, and RESOLVE: The National Infertility Association announced today they will ring the Nasdaq Stock Market [...]

Teladoc Announces U.S. Launch of Behavioral Health Navigator

25/04/2018 - 14:35

First Comprehensive Suite of Telebehavioral Health Services Improves Accuracy, Care Coordination and Access, to Drive Improved Outcomes PURCHASE, NY, April 25, 2018 (GLOBE NEWSWIRE) -- Teladoc , Inc. (NYSE: TDOC ), the [...]

Cesca Therapeutics Inc. to Exhibit at Several Upcoming Cell Therapy Conferences

25/04/2018 - 14:30

RANCHO CORDOVA, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca” or the “Company”) (NASDAQ: KOOL ) today announced that the Company will be exhibiting its full suite of cellular processing [...]

Sientra to Showcase OPUS™ Breast Products and miraDry fresh™ Procedure at American Society of Aesthetic Plastic Surgeons Meeting

25/04/2018 - 14:30

Unveils Sientra Platinum20™ Best in Class Warranty Program for OPUS Breast Implants Announces Preliminary Unaudited First Quarter 2018 Net Sales of Approximately $14.5 Million SANTA BARBARA, Calif., April 25, 2018 ( [...]

Profound Medical to Present at the 2018 Bloom Burton & Co. Healthcare Investor Conference

25/04/2018 - 14:30

TORONTO, April 25, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V: PRN ) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]

Ascendis Pharma A/S Announces Upcoming Investor Presentations

25/04/2018 - 14:30

COPENHAGEN, Denmark, April 25, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND ), a clinical stage biopharmaceutical company that applies its innovative TransCon technology to address significant unmet [...]